Intended for healthcare professionals

Letters Challenge of multimorbidity

Amplifying the impact of clinical pharmacology and therapeutics

BMJ 2020; 368 doi: (Published 27 February 2020) Cite this as: BMJ 2020;368:m717
  1. Emma H Baker, professor of clinical pharmacology1,
  2. Jamie Coleman, professor of clinical pharmacology2,
  3. David Webb, professor of clinical pharmacology3
  1. 1St George’s, University of London, London SW17 0RE, UK
  2. 2University of Birmingham, Birmingham, UK
  3. 3University of Edinburgh, Edinburgh, UK
  1. ebaker{at}

As clinical pharmacologists representing a truly generalist specialty, spanning all ages and organs, we welcome the call for rebalancing of specialist and generalist skills to improve care for patients with multimorbidity.1

Clinical pharmacology and therapeutics (CPT) arose in the last century in response to the explosive development of new drugs and parallel evolution of medicines regulation. In the 1970s, the …

View Full Text

Log in

Log in through your institution


* For online subscription